Abstract

NanomedicineVol. 3, No. 3 EditorialFree AccessQuantum dots for tumor-targeted drug delivery and cell imagingR DK MisraR DK MisraCenter for Structural & Functional Materials, University of Louisiana at Lafayette, PO Box 44130, Lafayette, LA 70504-4130, USA. Search for more papers by this authorEmail the corresponding author at dmisra@louisiana.eduPublished Online:29 May 2008https://doi.org/10.2217/17435889.3.3.271AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail Figure 1. Flow chart for the synthesis of water-dispersible Mn-doped ZnO quantum dots.DEA: Diethanolamine; QD: Quantum dot.Figure 2. Representation of the encapsulation of ZnO:Mn2+ quantum dots with folate-conjugated chitosan (2) and the drug-loading step (3) in which biofunctionalized chitosan loaded with drug is used to coat quantum dots.Early detection of cancer and targeted drug delivery, specifically in and around tumors and at concentrations that would decrease the growth rate and/or viability of the tumors, continues to be the primary challenge in the treatment of cancer. In many cases, the malignancy of tumors is detected only at advanced stages when chemotherapeutic drugs become increasingly toxic to healthy cells. To reduce this problem, targeted drug delivery and early detection of cancer cells continue to be investigated extensively. A tumor-targeting drug delivery system generally consists of a tumor-recognition moiety and a drug-loaded vesicle. Detection systems often involve invasive methods, such as tissue biopsy and sophisticated diagnostics tools, such as magnetic resonance imaging. However, there is no known single system currently that is capable of targeting drug delivery and imaging the delivery process simultaneously. An excellent vehicle to accomplish this objective is to develop a single system that is capable of targeting drug delivery and imaging the delivery process simultaneously to monitor the time course of subcellular location. Integration of biomaterials and semiconductor nanocrystal quantum dots (QDs) fields has good potential for addressing the current problems faced in cancer therapy by using biodegradable chitosan (N-acetyglucosamine) for tumor-targeted drug delivery and QDs for noninvasive imaging. The drug-loaded chitosan-encapsulated ZnO:Mn2+ QDs represent a potential platform to deliver tumor-targeted drugs and document the delivery process simultaneously [Hein S, Pers. Comm.].Doping enables us to tune into desired fluorescence emission. The doping of ZnO with low concentration of manganese is expected to increase the band-gap energy of ZnO with a consequent increase in luminescence. Considering that the high-molecular-weight chitosan of approximately 200 kDa can increase the size of QDs, the use of low-molecular-weight chitosan of approximately 50 kDa is preferred. Furthermore, to increase the efficiency of QD solubilization in aqueous medium, fully deacetylated chitosan prepared by thermochemical deacetylation is favored [Hein S, Pers. Comm.] [1]. Subsequently, the low-molecular-weight, fully deacetylated chitosan can be conjugated with folic acid for in situ encapsulation of water-dispersible ZnO:Mn2+ QDs. A possible flow chart for the synthesis of Mn-doped ZnO QDs is presented in Figure 1, based on some practices reported in the literature [2,3].The role of diethanolamine (DEA) in Figure 1 includes: preventing aggregation of QDs; coordinating with unsaturated metal atoms on the QD surface to prevent the formation of bulk semiconductors by coordination of N in DEA with the unsaturated metal ions [2–4]; and providing hydroxide (OH-) ions for the synthesis and stability of QDs [2]. The surfactant, oleic acid (OA), is believed to have carboxyl groups that react with the hydroxyl group of DEA and forms a complex on the surface of QDs, resulting in high stability in the aqueous medium [2,3]. Retention of coordinating organic ligands is necessary for maintaining the optical properties of QDs and for shielding the QDs from the environment. The presence of chemically bonded OA groups on the surface is expected to provide stability to the QDs in the aqueous medium. Furthermore, the hydroxyl group (OH-) of the DEA molecules will contribute additionally to the stability of nanocrystal QDs in the aqueous environment [2].Given that a high-molecular-weight chitosan can increase the size of QDs, use of a low-molecular-weight chitosan of approximately 50 kDa is preferred [Hein S, Pers. Comm.]. Furthermore, to increase the efficiency of QD solubilization in aqueous medium, fully deacetylated chitosan is favored. Chitosan is a linear polysaccharide copolymer of D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit). The degree of deacetylation (%DD) determines the content of free amino groups in the polysaccharides and is the key chemical characteristic that dictates the physicochemical and biological properties, including sorption property and metal chelation, change of solubility in dilute acid, biocompatibility and biodegradability. %DD affects the crystallinity and hydrophilicity of chitosan owing to variations in hydrophilic interactions that ultimately control the ligand attachment, drug loading and release characteristics of chitosan [5–7]. In general, the process of deacetylation involves the removal of an acetyl group (NHCOCH3) from the molecular chain and this obtains a complete and chemically reactive amino group (-NH2). The functionality and properties of chitosan essentially depend on the chemical-reactive amino group.Considering that, the preferred approach is to encapsulate ZnO:Mn2+ QDs with folate-conjugated chitosan. This involves synthesis of the folate-chitosan conjugation, followed by encapsulation of ZnO:Mn2+ QDs with folate-conjugated chitosan to get folate-chitosan-ZnO:Mn2+ QD nanoparticles (Figure 2). The nature of a cationic polyelectrolyte that has one amino group and two hydroxyl groups of chitosan provides a strong electrostatic interaction with negative-charged biomolecules and QDs [8]. The folic acid binding covalently to chitosan maintains the nanoparticle size, while keeping a positive-charge ratio of more than +2. Thus, the low-molecular-weight (50 kDa) and fully deacetylated chitosan can be conjugated with folic acid. Because folic acid is difficult to conjugate to the surface of the polymer, owing to the low reactivity of the carboxylic acid group, the carboxyl group of folic acid is first activated.It is expected that the drug-loaded, biofunctionalized chitosan-encapsulated QDs will enhance the cellular apoptosis of tumor cells [1]. Recently, it was observed that chitosan exhibits good proliferation of transfected cells [Thein-Han WW, Misra RDK, Unpublished Data]. Moreover, by using drug-loaded, biofunctionalized chitosan-encapsulated QDs, the time taken for tumor cells to go into an apoptotic state can also be monitored by confocal laser-scanning microscope. This information will determine the dosage necessary for targeted drug delivery [Hein S, Pers. Comm.].AcknowledgementsSome of the viewpoints expressed here are an outcome of scientific interaction and communication with San Hein and those expressed in the open literature. Thus, they are not necessarily solely of the author. Any omission of references is unintentional.Financial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.Bibliography1 Domard A, Rinado M: Preparation and characterization of fully deacetylated chitosan. Int. J. Biol. Macromol.5,49 (1983).Crossref, CAS, Google Scholar2 Fu YS, Du XW, Sun J, Song SF, Liu J: Single-crystal ZnO cup based on hydrothermal decomposition route. J. Phys. Chem. C.111,3863 (2007).Crossref, CAS, Google Scholar3 Fu YS, Du XW, Kulinich SA et al.: Stable aqueous dispersion of ZnO quantum dots with strong blue emission via simple solution route. J. Am. Chem. Soc.129,16029–16033 (2007).Crossref, Medline, CAS, Google Scholar4 Norberg NS, Kittilstved KR, Amonette JE, Kukkadapu RK, Schwartz DA, Gamelin DR: Synthesis of colloidal Mn2+:ZnO quantum dots and high-TC ferromagnetic nanocrystalline thin films. J. Am. Chem. Soc.126,9387–9398 (2004).Crossref, Medline, CAS, Google Scholar5 Kim TH, Park IK, Nah JW, Choi YJ, Cho CS: Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials25,3783–3792 (2004).Crossref, Medline, CAS, Google Scholar6 Gupta KC, Jabrail FH: Effects of degree of deacetylation and cross-linking on physical characteristics, swelling and release behavior of chitosan microspheres. Carbohydr. Polym.66,43 (2006).Crossref, CAS, Google Scholar7 Hsu SH, Whu SW, Tsai C, Wu YH, Chen HW, Hsieh KH: Chitosan as scaffold materials: effects of molecular weight and degree of deacetylation. J. Polymer Res.11,141 (2004).Crossref, CAS, Google Scholar8 Tan WB, Zhang Y: Surface modification of gold quantum dots nanoparticles. J. Biomed. Mater. Res. A.75,56 (2005).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetailsCited ByApplication of quantum dots in biomedical and biotechnological fieldsStability strategies of perovskite quantum dots and their extended applications in extreme environment: A reviewMaterials Research Bulletin, Vol. 156Bio-synthesis of ZnO nanoparticles and their in-situ coating on cotton fabric using Azadirachta Indica leaf extract for enhanced antibacterial activity20 September 2021 | Materials Technology, Vol. 37, No. 11Cooperation effects of Cu and Mn impurities inducing the formation of hollow shell structured ZnS quantum dots13 June 2021 | Materials Technology, Vol. 37, No. 10Multifunctional liposome-quantum dot hybrid nanocarriers for drug targeting to brain tumorsA novel strategy for site selective spin-labeling to investigate bioactive entities by DNP and EPR spectroscopy1 July 2021 | Scientific Reports, Vol. 11, No. 1Pharmaceutical Applications of Quantum Dots2 September 2021 | AAPS PharmSciTech, Vol. 22, No. 7Polymer dots and derived hybrid nanomaterials: A review13 April 2021 | Journal of Plastic Film & Sheeting, Vol. 37, No. 4Structural, optical and dielectric properties of Al/Mn doped ZnO nanoparticles, a comparative study16 June 2020 | Materials Technology, Vol. 36, No. 9Effect on optical and structural parameters in heavy Ca-doped ZnO nanostructures5 June 2020 | Materials Technology, Vol. 36, No. 9Rise in UV and blue emission and reduction of surface roughness due to the presence of Ag and Al in monocrystalline ZnO films grown by sol-gel spin coating11 June 2020 | Materials Technology, Vol. 36, No. 9Structural and functional properties of rare earth-based (NiO-CGO) nanocomposite produced by effective multiple doping approach via co-precipitation23 April 2020 | Materials Technology, Vol. 36, No. 5Quantum dots: Prospectives, toxicity, advances and applicationsJournal of Drug Delivery Science and Technology, Vol. 61Nanoparticles in medical imagingInduced electrostatic fields on optical gain in a polar quantum dotChemical Physics Letters, Vol. 760Blue-shift in the optical band gap of sol-gel derived Zn(1-x)SrxO nanoparticlesSolid State Sciences, Vol. 108A Novel Ratiometric Fluorescent Probe for Ag+ Based on Arginine-Naphthalene Imide12 August 2020 | Journal of Materials Engineering and Performance, Vol. 29, No. 8White emissive alloyed core–shell CdSe 1-x S x /ZnSe QDs: synthesis via a novel approach, investigating optical properties and application for photodegradation of methyl orange (MO)9 November 2019 | Materials Technology, Vol. 35, No. 6Carbon dots: Current advances in pathogenic bacteria monitoring and prospect applicationsBiosensors and Bioelectronics, Vol. 156High-quality quantum dots for multiplexed bioimaging: A critical reviewAdvances in Colloid and Interface Science, Vol. 278One-step synthesis, characterisation, photocatalytic and bio-medical applications of ZnO nanoplates17 September 2019 | Materials Technology, Vol. 35, No. 2Phonon Engineering in Nanostructures for Targeted Drug Delivery11 May 2019Lectin Nanoconjugates for Targeted Therapeutic Applications24 May 2020Pharmaceutical potential of quantum dots7 December 2017 | Artificial Cells, Nanomedicine, and Biotechnology, Vol. 46, No. sup1Fabrication and dual imaging properties of quantum dot/silica core-shell particles immobilized with gold nanoparticles31 July 2018 | Materials Technology, Vol. 33, No. 11Hybrid Gold/Silica/Quantum-Dots supramolecular-nanostructures encapsulated in polymeric micelles as potential theranostic tool for targeted cancer therapyEuropean Polymer Journal, Vol. 105A Facile Approach for Doxorubicine Delivery in Cancer Cells by Responsive and Fluorescent Core/Shell Quantum Dots15 June 2018 | Bioconjugate Chemistry, Vol. 29, No. 7Preparation and characterization of ZnSe quantum dots by the cation-inverting-injection method in aqueous solution31 October 2017 | Materials Technology, Vol. 33, No. 3Functionalized 2D nanomaterials for gene delivery applicationsCoordination Chemistry Reviews, Vol. 347Laser induced optical and microscopic studies of salicylic acid influenced KH 2 PO 4 crystal for photonic device applications5 May 2017 | Materials Technology, Vol. 32, No. 9Novel electrochemical biosensor based on PVP capped CoFe 2 O 4 @CdSe core-shell nanoparticles modified electrode for ultra-trace level determination of rifampicin by square wave adsorptive stripping voltammetryBiosensors and Bioelectronics, Vol. 92Preparation and characterization of magnetic fluorescent microspheres for delivery of kaempferol16 March 2016 | Materials Technology, Vol. 32, No. 3Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy2 February 20173.19 High Resolution Fluorescence Imaging of Cell–Biomaterial Interactions ☆Quantum Dots in Targeted Delivery of Bioactives and ImagingTargeted anticancer drug delivery through anthracycline antibiotic bearing functionalized quantum dots27 October 2015 | Artificial Cells, Nanomedicine, and Biotechnology, Vol. 44, No. 7Investigation on fluorescence, third order non-linear optical and mechanical performance of glycine doped ADP crystal for applications of photonic devices15 February 2016 | Materials Technology, Vol. 31, No. 4Pharmaceutical and biomedical applications of quantum dots10 June 2015 | Artificial Cells, Nanomedicine, and Biotechnology, Vol. 22Thermal Cancer Ablation Therapies Using Nanoparticles29 November 2016Facile synthesis of ternary CdMnS QD-based hollow nanospheres as fluorescent/magnetic probes for bioimaging1 January 2016 | Journal of Materials Chemistry B, Vol. 4, No. 7Improved C 2 H 2 sensing properties of Ni doped ZnO nanorods4 May 2015 | Materials Technology, Vol. 30, No. 6Morphology and field emission properties of tetrapod shaped Sn doped ZnO nanostructures under different growth times28 March 2015 | Materials Technology, Vol. 30, No. 6Hydrothermal synthesis of different CuO nano-flowers and their gas sensing property27 November 2014 | Materials Technology, Vol. 30, No. 4Effect of oxygen partial pressure on properties of ZnO/Al thin films prepared by pulsed dc reactive magnetron sputtering with SpeedFlo controller27 January 2015 | Materials Technology, Vol. 30, No. 4Bifunctional nanocomposites Fe 3 O 4 /MOS/CdTe with magnetic and luminescent functionalities30 May 2014 | Materials Technology, Vol. 29, No. 6Structural and physicochemical aspects of silica encapsulated ZnO quantum dots with high quantum yield and their natural uptake in HeLa cells30 September 2013 | Journal of Biomedical Materials Research Part A, Vol. 102, No. 9Development and biomedical application of nanocomposites: in situ fabrication of ZnO–PbO nanocomposite through microwave method24 March 2014 | Materials Technology, Vol. 29, No. 4‘Smart’ gold nanoshells for combined cancer chemotherapy and hyperthermia13 February 2014 | Biomedical Materials, Vol. 9, No. 2Influence of reactant concentration on optical properties of ZnO nanoparticles6 December 2013 | Materials Technology, Vol. 29, No. 2Current and Future Lymphatic Imaging Modalities for Tumor StagingBioMed Research International, Vol. 2014Multicolor multicycle molecular profiling with quantum dots for single-cell analysis5 September 2013 | Nature Protocols, Vol. 8, No. 10Photonic antioxidant ZnS(Cd) nanorod synthesis for drug carrier and bioimaging18 November 2013 | Materials Technology, Vol. 28, No. 4Quantum dots: heralding a brighter future for clinical diagnosticsTamer M Samir, Mai MH Mansour, Steven C Kazmierczak & Hassan ME Azzazy4 December 2012 | Nanomedicine, Vol. 7, No. 11Progress of Nanobiomaterials for Theranostic Systems16 October 2012Tapping the potential of quantum dots for personalized oncology: current status and future perspectivesChuang Chen, Jun Peng, Sheng-Rong Sun, Chun-Wei Peng, Yan Li & Dai-Wen Pang2 March 2012 | Nanomedicine, Vol. 7, No. 3Preparation and Analytical Applications of Quantum DotsAdvances in lymphatic imaging and drug deliveryAdvanced Drug Delivery Reviews, Vol. 63, No. 10-11Optical applications of quantum dots in biological system20 August 2011 | Science China Chemistry, Vol. 54, No. 8Fluorescence Imaging of Cell–Biomaterial InteractionsQD-“Onion”-Multicode silica nanospheres with remarkable stability as pH sensorsJournal of Materials Chemistry, Vol. 21, No. 44Antibody engineering promotes nanomedicine for cancer treatmentJie Gao, Si-Shen Feng and Yajun Guo1 November 2010 | Nanomedicine, Vol. 5, No. 8In Vivo Imaging of Sentinel Nodes Using Fluorescent Silica Nanoparticles in Living Mice15 October 2009 | Molecular Imaging and Biology, Vol. 12, No. 2Targeted hyperthermia using metal nanoparticlesAdvanced Drug Delivery Reviews, Vol. 62, No. 3Use of Nanoparticles for Targeted, Noninvasive Thermal Destruction of Malignant Cells25 January 2010Detection of Bifidobacterium Species-specific 16S rDNA Based on QD FRET Bioprobe26 September 2009 | Journal of Fluorescence, Vol. 20, No. 1Designing multifunctional quantum dots for bioimaging, detection, and drug deliveryChemical Society Reviews, Vol. 39, No. 11Nanoscale assembly of mesoporous ZnO: A potential drug carrierJournal of Materials Chemistry, Vol. 20, No. 31Effect of particle shape on phagocytosis of CdTe quantum dot–cystine compositesMedChemComm, Vol. 1, No. 1Nanoparticles for biomedical imaging10 September 2009 | Expert Opinion on Drug Delivery, Vol. 6, No. 11Polymeric carriers: role of geometry in drug delivery1 December 2008 | Expert Opinion on Drug Delivery, Vol. 5, No. 12 Vol. 3, No. 3 Follow us on social media for the latest updates Metrics History Published online 29 May 2008 Published in print June 2008 Information© Future Medicine LtdAcknowledgementsSome of the viewpoints expressed here are an outcome of scientific interaction and communication with San Hein and those expressed in the open literature. Thus, they are not necessarily solely of the author. Any omission of references is unintentional.Financial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call